Since IDO1 is expressed in normal pet rabbit mammary tissue, systemic administration of an inhibitor of the IDO1 pathway could potentially lead to local site effects, which could be avoided by selecting therapeutic modes that selectively target the tumor tissue, such as antibody drug conjugates [49]. The gene discussed is IDO1; the disease is neoplasm.